Yahoo Web Search

Search results

    • Novel PCSK9 Inhibitor Reduced LDL by 50%

      Novel PCSK9 Inhibitor Reduced LDL by 50%

      Medscape· 6 days ago

      Lerodalcibep, a novel, third-generation proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitor, reduced low-density lipoprotein cholesterol...